Genetic variants of the leptin and leptin receptor genes in cancer patients have been described in some studies and are associated with decreased risk of cancer susceptibility, smaller tumor size, less node and distant metastasis, and less distant metastasis [225], although other polymorphisms are related to an increase in tumorigenesis [226]. This evidence concerns the gene LEPR and neoplasm.